Cargando...
Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectives
Immune-checkpoint inhibitors have become valuable therapies in the treatment of patients with non-small-cell lung cancer (NSCLC). Recent clinical trials have shown promising results with regard to efficacy and toxicity profiles of these agents compared to cytotoxic chemotherapy. Nivolumab was one of...
Gardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5533488/ https://ncbi.nlm.nih.gov/pubmed/28769573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S97903 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|